Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NDC-002 by DR.Noah Biotech for Dementia: Likelihood of Approval
NDC-002 is under clinical development by DR.Noah Biotech and currently in Phase I for Dementia. According to GlobalData, Phase I...